WuXi AppTec (HKG:2359, SHA:6032599) clarified media reports regarding plans to offload its ATU or advanced therapies business, saying it is still weighing its options for the continuation of the business unit, according to a Tuesday filing with the Hong Kong Stock Exchange.
The biotechnology company has not decided on the matter, and is assessing its options according to its priorities of employees and patients, the filing said.
"There is uncertainty as to whether the Company will eventually decide to dispose WuXi ATU," it said in the filing.
Shares plunged 13% in Hong Kong and gained 10% in Shanghai during Tuesday's afternoon trading.
Price (HKD): $59.80, Change: $-9.2, Percent Change: -13.33%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。